HIGHLIGHTS
- who: Gloria Magro and collaborators from the Instituto de Salud Carlos III (ISCIII), Spain University of North Carolina Hospitals have published the article: How to break free: HIV-1 escapes from innovative therapeutic approaches, in the Journal: (JOURNAL)
- what: Actually, due to HIV-1 variability, this antibody combination has been predicted to function in around 50% of HIV-1 clade Binfected patients, requiring to add or substitute one of the bNAbs frontiersin.org 10.3389/fviro.2022.933418 often combined with complementary approaches aimed at inducing apoptosis, as reviewed in_(52), or at boosting the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.